Iovance Biotherapeutics Inc (IOVA) is up Wednesday morning, with the stock increasing 5.31% in pre-market trading to 17.44. IOVA’s short-term technical score of 26 indicates that the stock has traded less bullishly over the last month than 74% of stocks on the market. In the Biotechnology industry, which ranks 135 out of 146 industries, Iovance Biotherapeutics Inc ranks higher than 45% of stocks. Iovance Biotherapeutics Inc has risen 27.68% over the past month, closing at $ 13.72 on March 9. During this period of time, the stock fell as low as $ 12.38 and as high as $ 18.34. IOVA has an average analyst recommendation of Strong Buy. The company has an average price target of $ 36.30.
Iovance Biotherapeutics Inc has a Long-Term Technical rank of 24. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 76% of the market scoring higher. In the Biotechnology industry which is number 127 by this metric, IOVA ranks better than 35% of stocks.
Important Dates for Investors in IOVA:
-Iovance Biotherapeutics Inc is set to release earnings on 5/5/2022. Over the last 12 months, the company has reported EPS of $ -2.22. -We do not have a set dividend date for Iovance Biotherapeutics Inc at this time. Click Here To Get The Full Report on Iovance Biotherapeutics Inc (IOVA)
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.